... earned:
This session: ...
Per second: ...
← Back to list
Phillip Frost
#1741

Phillip Frost

Source of wealth: Pharmaceuticals

Net Worth

...

Earnings per second

...

Modules

Biography

A long-time health care investor, inventor and founder, Phillip Frost now runs diagnostics-maker Opko Health.

Frost joined Key Pharmaceuticals in 1972, reformulated its asthma drug and sold the company in 1986 for $836 million.

Frost founded Ivax, a generic drugmaker, in 1987. He sold it to Teva Pharmaceuticals for $7.6 billion in 2005.

In 2018, the SEC accused him of participating in a "pump-and-dump" scheme that generated over $27 million from unlawful stock sales.

Frost denied the allegations in a personal statement. He settled with the SEC in 2018 without admitting or denying the allegations.

Financial Assets

Exchange
NYSE AMERICAN
Ticker
ADGE-US
Company
American DG Energy Inc
Exchange
NYSE AMERICAN
Ticker
ASXC-US
Company
Asensus Surgical Inc
Exchange
NASDAQ
Ticker
BCDA-US
Company
BioCardia
Exchange
NASDAQ
Ticker
COCP-US
Company
Cocrystal Pharma
Exchange
NASDAQ
Ticker
COCP-US
Company
Cocrystal Pharma
Exchange
NYSE
Ticker
DOUG-US
Company
Douglas Elliman
Exchange
US OTC
Ticker
COMS-US
Company
Drone Aviation
Exchange
NASDAQ
Ticker
FLNT-US
Company
Fluent
Exchange
NASDAQ
Ticker
IGNYU-US
Company
Ignyte Acquisition Corp
Exchange
NASDAQ
Ticker
NXPL-US
Company
NextPlat
Exchange
NASDAQ
Ticker
NAGE-US
Company
Niagen Bioscience
Exchange
US OTC
Ticker
NNUP-US
Company
Nocopi Technologies
Exchange
US OTC
Ticker
NIMU-US
Company
Non-Invasive Monitoring Systems Inc.
Exchange
NASDAQ
Ticker
OPK-US
Company
Opko Health
Exchange
NASDAQ
Ticker
OPK-US
Company
Opko Health
Exchange
NASDAQ
Ticker
OPK-US
Company
Opko Health
Exchange
NASDAQ
Ticker
OPK-US
Company
Opko Health
Exchange
NASDAQ
Ticker
OPK-US
Company
Opko Health
Exchange
NASDAQ
Ticker
OPK-US
Company
Opko Health
Exchange
NASDAQ
Ticker
OPK-US
Company
Opko Health
Exchange
NASDAQ
Ticker
OPK-US
Company
Opko Health
Exchange
US OTC
Ticker
PKBO-US
Company
Peak Bio, Inc.
Exchange
NYSE
Ticker
PFE-US
Company
Pfizer
Exchange
HONG KONG
Ticker
6808-HK
Company
Sun Art Retail Group Limited
Exchange
NYSE
Ticker
TEVA-US
Company
Teva Pharmaceutical Industries Ltd.
Exchange
NYSE
Ticker
VGR-US
Company
Vector Group Ltd.
Exchange
NASDAQ
Ticker
VERU-US
Company
Veru

The Great Lie of Mega-Fortunes: The Case of Phillip Frost

Billionaires are often presented under the romantic myth of the 'self-made person': a narrative designed to justify opulence as the natural reward for hard work, effort, or ingenuity. However, when confronting such extreme volumes of wealth with macroeconomic reality, the meritocracy narrative completely breaks down. No individual can legitimately generate through personal effort a fortune equivalent to millions of times the average working-class salary. Capital at the top does not grow because of exceptional talent; it expands through an implacable dynamic where accumulated money works exponentially faster than people, devouring the wealth generated by productive labor.

The immense fortune of Phillip Frost, linked to Healthcare and 'Pharmaceuticals', has not been built in a free-market vacuum, but through rent-seeking, the use of exclusive elite influence, the consolidation of monopoly positions, or inherited wealth. Far from taking real private risks, billionaire empires structurally depend on state support through direct subsidies, infrastructure use, exploitation of R&D, public contracts, and offshore tax engineering. While this wealth is equivalent to the physical weight of 17 tons of pure gold, the rest of the planet suffers from an artificial scarcity of basic resources. The fact that this wealth is enough to fully fund the public health system of DR Congo, a country with more than 105800000 million inhabitants for 1.1 years, proves that unlimited accumulation is not an entrepreneurial achievement, but the hijacking of democratic sovereignty.

Share

𝕏 Share on X 💬 Send via WhatsApp ✈️ Send via Telegram f Share on Facebook